Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Caladrius Biosciences

Caladrius Biosciences
1980 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
CLBS STOCK SYMBOL
4 INVESTMENTS
$3.00 SHARE PRICE (As of Friday Closing)
Description

Caladrius Biosciences Inc is a therapeutics development biopharmaceutical company. It is engaged in the development of products that have the potential to restore the health of people with chronic illnesses. The company' product candidates include three developmental treatments for cardiovascular diseases; CLBS12 for the treatment of critical limb ischemia (CLI); CLBS14-CMD for the treatment of coronary microvascular dysfunction (CMD); CLBS14-NORDA for no-option refractory disabling angina (NORDA); and one autoimmune product candidate, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of Type 1 diabetes.

Formerly Known As
Phase III Medical, Corniche Group, Neostem
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 106 Allen Road
  • 4th Floor
  • Basking Ridge, NJ 07920
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Caladrius Biosciences’s full profile, request a free trial.

Caladrius Biosciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.77 - $11.65 $31.1M $3.01 -$1.58 29.8K 10.4M

Caladrius Biosciences Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value (8,879) (24,405) 39,901 10,121
Revenue 0 0 0 0
EBITDA (15,392) (15,938) (26,948) (29,028)
Net Income (15,551) (16,167) 22,979 (32,656)
Total Assets 41,288 44,580 63,376 53,514
Total Debt 0 159 8,056
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Caladrius Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Caladrius Biosciences‘s full profile, request access.

Request full access to PitchBook

Caladrius Biosciences Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Baliopharm Corporate Backed or Acquired Basel, Switzerland 000000&0
0000000 0000000000 Venture Capital-Backed Malvern, PA 0 000.00 00000000000 000.00
0000000 0000000000 Corporation San Diego, CA 00 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Dublin, Ireland 00 00000 00000000000 00000
0.0. 0000 0000 Formerly VC-backed Sunrise, FL 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Caladrius Biosciences Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000 00 08-May-2014 000000000000000000 0000 Biotechnology
00000000 25-Jul-2011 0000000000 00.00 Biotechnology
000 20-Jan-2011 000000000000000000 Biotechnology 00000 00000 00.0
Stem Cell Technologies 14-Nov-2007 Merger/Acquisition Biotechnology 00000 00000 00
To view this company’s complete investment and acquisition history, request access »

Caladrius Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 20-Jan-2011 000000000000000000 Completed
  • 000000000 00000000
To view this company’s complete exits history, request access »

Caladrius Biosciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Caladrius Biosciences‘s full profile, request access.

Request full access to PitchBook

Caladrius Biosciences Executive Team (15)

Name Title Board
Seat
Contact
Info
David Mazzo Ph.D Chief Executive Officer & Director
Joseph Talamo Senior Vice President & Chief Financial Officer
Richard Berman JD Director
Lawrence May MD Vice President, Strategic Initiatives
Douglas Losordo Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer

8 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Caladrius Biosciences Board Members (7)

Name Representing Role Since Contact
Info
0000 000000000 Self Director, Chairman of Audit Committee 000 0000
000000 000000000 Self Director, Member of Audit, Governance and Nominating Committee 000 0000
00000 000000 Caladrius Biosciences Board Member 000 0000
000000 00000 00 Self Board Member 000 0000
000000 00000 Self Lead Director & Chairman, Governance & Nominating Committee 000 0000

2 Former Board Members

You’re viewing 5 of 7 board members. Get the full list »